Physician profile
Douglas A Wolfe
NPI 1861411621
$8,736.68
in general payments reported to CMS, 2019-2025
24 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,885 · 2020: $234 · 2021: $678 · 2022: $373 · 2023: $2,295 · 2024: $1,941 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,594 · Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,593.53 |
| Food and Beverage | $1,972.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,837.17 | 2019-2020 | |
| Boston Scientific Corporation | $1,766.68 | 2020-2025 | Watchman Access System, Mylux Patient Kit With Mobile Device, Latitude Communicator Power Supply |
| Atricure, INC. | $1,622.26 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $548.71 | 2020-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $444.46 | 2019-2025 | |
| Medtronic, INC. | $258.04 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II |
| Pfizer INC. | $239.14 | 2019-2024 | |
| Genzyme Corporation | $234.71 | 2023-2025 | |
| Livanova USA, INC. | $210.71 | 2019-2021 | |
| Amgen INC. | $187.43 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $183.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $183.11 | 2019-2022 | |
| Akcea Therapeutics, INC. | $173.83 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $166.49 | 2022-2024 | Verquvo |
| Cvrx, INC. | $149.78 | 2023 | Barostim Neo System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $147.47 | 2019-2024 | Absolute Pro |
| Biotronik INC. | $134.50 | 2019-2023 | Edora 8 Dr-T, Acticor 7 Vr-T Dx, Biomonitor |
| E.R. Squibb & Sons, L.L.C. | $96.86 | 2021-2022 | |
| Gilead Sciences, INC. | $46.78 | 2019 | |
| Lundbeck LLC | $40.58 | 2019 | |
| Astellas Pharma US INC | $23.25 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.48 | 2020 | |
| Amarin Pharma, INC. | $15.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.44 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.